Back to Search
JOSEPHINE MONTANA, M.D
M.D
Family Medicine Physician
NPI: 1417984782IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
C54399(CA)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
OTHER
Class of 1979
Research & Publications (18)
The design of selective non-substrate-based matrix metalloproteinase inhibitors.
PMID 19649867·Curr Opin Drug Discov Devel·2000
8-other
Maraviroc for previously treated patients with R5 HIV-1 infection.
PMID 18832244·N Engl J Med·2008
3-trial
Action of (R)-sila-venlafaxine and reboxetine to antagonize cisplatin-induced acute and delayed emesis in the ferret.
PMID 18675289·Toxicol Appl Pharmacol·2008
7-preclinical
Trimethylsilylpyrazoles as novel inhibitors of p38 MAP kinase: a new use of silicon bioisosteres in medicinal chemistry.
PMID 17095218·Bioorg Med Chem Lett·2007
7-preclinical
(R)-sila-venlafaxine: a selective noradrenaline reuptake inhibitor for the treatment of emesis.
PMID 16513343·Bioorg Med Chem Lett·2006
4-observational
Pharmacology of N-(3,5-dichloro-1-oxido-4-pyridinyl)-8-methoxy-2-(trifluoromethyl)-5-quinoline carboxamide (SCH 351591), a novel, orally active phosphodiesterase 4 inhibitor.
PMID 12065709·J Pharmacol Exp Ther·2002
3-trial
Synthesis and profile of SCH351591, a novel PDE4 inhibitor.
PMID 12039576·Bioorg Med Chem Lett·2002
7-preclinical
8-Methoxyquinoline-5-carboxamides as PDE4 inhibitors: a potential treatment for asthma.
PMID 12039574·Bioorg Med Chem Lett·2002
8-other
7-Methoxyfuro[2,3-c]pyridine-4-carboxamides as PDE4 inhibitors: a potential treatment for asthma.
PMID 11814830·Bioorg Med Chem Lett·2002
7-preclinical
Update on the therapeutic potential of PDE4 inhibitors.
PMID 11772317·Expert Opin Investig Drugs·2002
6-review
Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitors.
PMID 11378378·Bioorg Med Chem Lett·2001
4-observational
Synthesis and structure-activity relationships of guanine analogues as phosphodiesterase 7 (PDE7) inhibitors.
PMID 11327595·Bioorg Med Chem Lett·2001
8-other
7-Methoxybenzofuran-4-carboxamides as PDE 4 inhibitors: a potential treatment for asthma.
PMID 10999488·Bioorg Med Chem Lett·2000
7-preclinical
Solid-phase synthesis and biological screening of N-alpha-mercaptoamide template-based matrix metalloprotease inhibitors.
PMID 10702612·Comb Chem High Throughput Screen·2000
8-other
Enzyme-linked immunosorbent assay to assess respiratory syncytial virus concentration and correlate results with inflammatory mediators in tracheal secretions.
PMID 10643842·Pediatr Infect Dis J·2000
3-trial
Primary respiratory syncytial virus infection: pathology, immune response, and evaluation of vaccine challenge strains in a new mouse model.
PMID 10618539·Vaccine·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 820 N MOUNTAIN AVE STE 103
UPLAND, CA 91786 - Phone
- (909) 236-5575
Quick Facts
- NPI
- 1417984782
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 47
- Publications
- 18
Are you this provider?
Claim Your Profile